the Effectivness of the Thoracic Cage Mobilization on COPD Patients
the Effectiveness of the Thoracic Cage Mobilization on Chronic Obstructive Pulmonary Disease Patients
1 other identifier
interventional
30
1 country
1
Brief Summary
the study aims to investigate effectiveness of thoracic cage mobilizations on the chronic obstructive pulmonary diseases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable chronic-obstructive-pulmonary-disease
Started Oct 2022
Shorter than P25 for not_applicable chronic-obstructive-pulmonary-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 22, 2022
CompletedFirst Posted
Study publicly available on registry
July 7, 2022
CompletedStudy Start
First participant enrolled
October 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedFebruary 17, 2023
February 1, 2023
1 month
June 22, 2022
February 15, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
ABG
to measure pH (7.35-7.45), PaO2 (75-100 mmHg), PaCO2 (35-45 mmHg), HCO3 (22-26 meq/L) and SaO2 (95-100%) we will measure these types of ABG Before and after the treatment and measure the difference before and after and compared it with the standard to detect the effect of the treatment on the lung function
up for one week
chest expansion with tape measurement
using tape to measure chest exp ansion during inspiration and expiration at axillary level and at the level of T10 using CM units
up for one week
Secondary Outcomes (2)
CAT questionnaire
up for one week
Dyspnea index
up for one week
Study Arms (2)
conventional treatment
EXPERIMENTALthe patient will receive conventional treatment daily for up to one week
thoracic cage mobilization
EXPERIMENTALthe patient will receive thoracic cage mobilization added to conventional treatment daily for up to one week
Interventions
the patient will be asked to make pursed lip breathing (Breathe in for 2 seconds through his nose and Breathe out for 4 seconds through pursed lips)for 5-10 min ,3-4 times , 8-10 rep each cycle then asked to make diaphragmatic breathing exercise (Lie on his/her back and Inhale deeply through his/her nose for a count of three)for 5-10 min , 3-4 times , 8-10 repetition then postural drainage , furthermore the patient takes different position (prone to make percussion on lower lobes, side lying on anterior basal segment then sitting position on the upper lobe). After that a vibration on the chest (place a flat hand firmly atop the lung segment to be drained., and should apply light pressure and create a rapid, shaking movement) 1 min inhale and 5 time of repetition at the exhale and finally asked the patient to make productive cough for 5 times to get out the sputum.
we will use A SNAG to mobilization using type 3 oscillatory and sustain for 90 second, at first put the patient in 3 position (side lying to make mobilization of upper 6 ribs in downward direction then make on lower 6 ribs ,furthermore flexion of the thoracic and next rotation toward the midline then ask the patient to transfer to supine lying position and mobilize the sternum in downward direction the next mobilize the clavicle and ask the patient to take sitting position and put his hand on his head in adduction position and make extension on the thoracic vertebrae with inward mobilize with the investigator knees ,take each 4 vertebrae along the 12 thoracic vertebrae.
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of chronic obstructive pulmonary disease.
- Age \>35 years.
- Received conventional medical treatment.
- the presence of at least two of the following three clinical criteria: a recent increase in breathlessness, sputum volume or sputum purulence.
- All enrolled patients either had previously been given a diagnosis of COPD by a physician or had at least a one-year history of chronic breathlessness or cough with sputum production
You may not qualify if:
- Admitted to the hospital, had been given a diagnosis of asthma or atrophy.
- Patients who had received oral or intravenous corticosteroid in the emergency department within the preceding 30 days.
- patient put on the mechanical ventilation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Mariam omran Grase
Giza, 12511, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- the patients , care provider and investigator do not know the groups receive treatment
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principle investigator
Study Record Dates
First Submitted
June 22, 2022
First Posted
July 7, 2022
Study Start
October 21, 2022
Primary Completion
December 1, 2022
Study Completion
December 1, 2022
Last Updated
February 17, 2023
Record last verified: 2023-02